quoted from here
Showing posts with label Oklahoma. Show all posts
Showing posts with label Oklahoma. Show all posts
Monday, January 13, 2014
Missouri Lawmakers Call For Investigation Into State's Execution Method-The calls follow a report by St. Louis Public Radio and the Beacon that found the department bought its execution drug, pentobarbital, from an Oklahoma compounding pharmacy that isn’t licensed to sell here
Several state lawmakers are calling for an investigation into how the Missouri Department of Corrections has carried out executions in the previous months.
The calls follow a report by St. Louis Public Radio and the Beacon that found the department bought its execution drug, pentobarbital, from an Oklahoma compounding pharmacy that isn’t licensed to sell here.
Under normal circumstances, the seller could be committing a felony.
“I don’t want our state to be able to do things the average citizen could not do,” House Minority Whip John Rizzo of Kansas City said. “I think it’s a very real possibility that our state is obtaining this drug from another state without the proper protocol.”
The Democrat is filing a bill on Monday that would create a temporary commission to see if the state was guilty of any wrongdoing. It would also place a hold on executions while they investigate.
continue to read here
The calls follow a report by St. Louis Public Radio and the Beacon that found the department bought its execution drug, pentobarbital, from an Oklahoma compounding pharmacy that isn’t licensed to sell here.
Under normal circumstances, the seller could be committing a felony.
“I don’t want our state to be able to do things the average citizen could not do,” House Minority Whip John Rizzo of Kansas City said. “I think it’s a very real possibility that our state is obtaining this drug from another state without the proper protocol.”
The Democrat is filing a bill on Monday that would create a temporary commission to see if the state was guilty of any wrongdoing. It would also place a hold on executions while they investigate.
continue to read here
Missouri is going too far on death penalty secrecy: A recent investigation by St. Louis Pubic Radio and the St. Louis Beacon upped the ante by pinpointing a compounding company in Oklahoma as the state’s possible, unlicensed source.
January 12
By MARY SANCHEZ
The Kansas City Star
The executioner was always hooded. Who fired the lethal shot? Who dropped the guillotine blade? Neither was revealed.
The modern equivalent still applies. But Missouri is stretching it to a ridiculous and possibly illegal level.Missouri is so intent on carrying out state-sanctioned murder that it might wind up slammed for breaking federal law.
Last week, the U.S. attorneys of the Eastern and Western Districts of Missouri asked the Food and Drug Administration-Office of Criminal Investigations to look into Missouri’s efforts to shield the drug company that provides lethal-injection doses of pentobarbital. The move was prompted by questions from death-penalty opponents.continue to read here
Thursday, January 2, 2014
1099 compounding sales jobs in Colorado, Georgia, Iowa, Indiana, Kansas, New Mexico, New Jersey, Minnesota, Missouri, Nevada, New York, Oklahoma, Texas, Washington
1099 Pharmaceutical Representative
NVYDiA Medical - Pharmaceutical Compound SalesIf you are currently in Pharmaceutical or Medical Sales and have established relationships with physicians (Primary Care, Internal Medicine, Neuro's, Ortho's, Plastic's, Podiatrists, Chronic Pain, Spine, Radiation Oncology, Hospice, Urology, Hand Surgeons, Lower/upper Extremity, Sports Medicine, Rheumatology, Rehabilitation, etc.) this is a great opportunity for you.This is not a position you have to leave your current job for. This is an opportunity for you to supplement your income with an additional revenue stream added to your existing salary. This opportunity can increase your yearly income without you going outside of your call pattern, if you have existing relationships. If you have solid contacts in medical, pharmaceutical or other healthcare industries, send your resume and we will contact you.Below is a general description of what you will be offering your physicians:First, we offer everyday used injectable drugs that are administered with in the clinic, for example, B-12, steroid injections, Testosterone injections, antibiotic injections, etc. Our business model has cut out the middle man to offer these products at a discounted price. What makes this sale so easy, is that we are offering products that the doctors or clinics are purchasing, we are just helping them save money.Second, pharmaceutical compounding, (done in compounding pharmacies) is the creation of a particular pharmaceutical product to fit the unique needs of a patient. To do this, compounding pharmacists combine or process appropriate ingredients using various tools. This may be done for medically necessary reasons, such as to change the form of the medication from a solid pill to a liquid, to avoid a non-essential ingredient that the patient is allergic to, or to obtain the exact dose needed. More recently it has been suggested that some doctors and clinics have turned away from major drug manufacturers and turned to compounding pharmacies because they often provide a much higher quality of product and charge much lower prices than the major manufacturers.Positions available in: Colorado, Georgia, Iowa, Indiana, Kansas, New Mexico, New Jersey, Minnesota, Missouri, Nevada, New York, Oklahoma, Texas, WashingtonFor those who meet the qualifications and are interested, send your resume to: resumes@nvydiamedical.com
Sunday, December 1, 2013
Frog Juice: Horse Racing’s New Doping Scandal--dermorphin found in Louisiana, Oklahoma, and New Mexicio race horses
June 21, 2012
More than 30 horses have now tested positive for an illegal performance-enhancing substance that makes even the grossest doping scandal of human athletes pale in comparison. Apparently, horse owners have been paying chemists to squeeze frogs in South America and send the slime that drips off the amphibians’ backs to trainers in the United States. According to a report in the New York Times Tuesday, traffic in dermomorphin, a drug obtained from the skin of the Phyllomedusa sauvagei, commonly known as the waxy monkey tree frog, has racing officials across four states concerned.
Dermorphin has the twofold benefit of both numbing the pain a horse might feel from an injury and simultaneously rendering the animal hyperactive. “For a racehorse, it would be beneficial,” Craig W. Stevens, a professor of pharmacology at Oklahoma State University, told the Times. “The animal wouldn’t feel pain, and it would have feelings of excitation and euphoria.” The effects of this painkiller are even more powerful than morphine.
(MORE: Murder on the Backside: The Unseen World of the Kentucky Derby)
Dermorphin is only one of many doping methods that have plagued racetracks over the years, though it’s definitely the most exotic — narrowly beating out cobra venom, which has been used as a pain suppressant. But doping in horse racing is a century-old tradition, going at least as far back as a case in England in the nineteenth century in which a man was executed for drugging a racehorse with arsenic. But in a sport in which fans are becoming increasingly concerned over animals’ welfare and the methods used to train them — not excluding this year’s triple crown favorite, I’ll Have Another, recently scratched from the Belmont Stakes — its a blow racing officials aren’t eager to take. “It couldn’t have come at a worse time,” said the executive director of the Louisiana Racing Commission, Charles A. Gardiner III. “We’re fighting back federal intervention. We’re under attack and losing our fan base.”
Labs have found dermorphin in Louisiana, Oklahoma, and New Mexico, and regulators suspect its use in Texas. Though frog juice rumors had been circulating for a long time, officials had been unable to identify the substance until a lab in Denver recently found the correct testing procedure. No trainers have been formally charged yet, though racing regulators say we can expect a crackdown soon.
However, don’t expect a crackdown to deter cheating. Edward J. Martin, president of Racing Commissioners International, bemoaned the fact that as soon as you crackdown on one drug, trainers move on to using another.
Read more: Frog Juice: Horse Racing’s New Doping Scandal | TIME.com http://newsfeed.time.com/2012/06/21/frog-juice-horse-racings-new-doping-scandal/#ixzz2mFrEUGxk
More than 30 horses have now tested positive for an illegal performance-enhancing substance that makes even the grossest doping scandal of human athletes pale in comparison. Apparently, horse owners have been paying chemists to squeeze frogs in South America and send the slime that drips off the amphibians’ backs to trainers in the United States. According to a report in the New York Times Tuesday, traffic in dermomorphin, a drug obtained from the skin of the Phyllomedusa sauvagei, commonly known as the waxy monkey tree frog, has racing officials across four states concerned.
Dermorphin has the twofold benefit of both numbing the pain a horse might feel from an injury and simultaneously rendering the animal hyperactive. “For a racehorse, it would be beneficial,” Craig W. Stevens, a professor of pharmacology at Oklahoma State University, told the Times. “The animal wouldn’t feel pain, and it would have feelings of excitation and euphoria.” The effects of this painkiller are even more powerful than morphine.
(MORE: Murder on the Backside: The Unseen World of the Kentucky Derby)
Dermorphin is only one of many doping methods that have plagued racetracks over the years, though it’s definitely the most exotic — narrowly beating out cobra venom, which has been used as a pain suppressant. But doping in horse racing is a century-old tradition, going at least as far back as a case in England in the nineteenth century in which a man was executed for drugging a racehorse with arsenic. But in a sport in which fans are becoming increasingly concerned over animals’ welfare and the methods used to train them — not excluding this year’s triple crown favorite, I’ll Have Another, recently scratched from the Belmont Stakes — its a blow racing officials aren’t eager to take. “It couldn’t have come at a worse time,” said the executive director of the Louisiana Racing Commission, Charles A. Gardiner III. “We’re fighting back federal intervention. We’re under attack and losing our fan base.”
Labs have found dermorphin in Louisiana, Oklahoma, and New Mexico, and regulators suspect its use in Texas. Though frog juice rumors had been circulating for a long time, officials had been unable to identify the substance until a lab in Denver recently found the correct testing procedure. No trainers have been formally charged yet, though racing regulators say we can expect a crackdown soon.
However, don’t expect a crackdown to deter cheating. Edward J. Martin, president of Racing Commissioners International, bemoaned the fact that as soon as you crackdown on one drug, trainers move on to using another.
Read more: Frog Juice: Horse Racing’s New Doping Scandal | TIME.com http://newsfeed.time.com/2012/06/21/frog-juice-horse-racings-new-doping-scandal/#ixzz2mFrEUGxk
Monday, October 21, 2013
IACP Regional Meeting Novembr 9, 2013, in Tulsa, Oklahoma
2013 Regional Education Meetings
- November 9, 2013 - Tulsa, Okla.
5:00 - 7:30 p.m.
Hyatt Regency Tulsa, Diplomat Room, 2nd Floor
100 East 2nd Street, Tulsa, OK 74103
Click Here to View the Event Flyer for More Details!
100 East 2nd Street, Tulsa, OK 74103
Click Here to View the Event Flyer for More Details!
This meeting is held in conjunction with Freedom’s November CPCSI training and the Freedom Pharmaceuticals 2nd Annual Seminar. For more information, please click her
Thursday, July 4, 2013
Oklahoma Board of Pharmacy Steps Up Pace on Disciplinary Action Against Compounding Pharmacies and Pharmacists Including Larry Kirkpatrick PIC and Vivien L. Grose of Red Cross Pharmacy; and Pharmacy of Pocola for fraudulent billing of compounding (2 cases 138 and 137 counts)
Disciplinary Actions
For more information, you may view hearing minutes at
www.pharmacy.ok.gov.
13.28. April 11, 2013 Board Hearing
Shannon Monteggia, Technician #17249 – Case No.
1160: Did not contest one violation of failure to obtain a
pharmacy technician permit prior to performing pharmacy
technician duties in a pharmacy. Permit placed on probation for ninety (90) days
and must attend a law seminar
in 2013. (Agreed Order)
Jason Lee O’Neal, DPh, #14970 – Case No. 1161: Did
not contest one violation of failure to supervise pharmacy
employees. Fine of $500, must attend law seminar in
addition to the required 15 hours of CE in 2013 and
2014, and all CE for 2013 and 2014 must be live. (Agreed
Order)
Ben Blackburn, DPh, #12179 – Case No. 1162: Did not
contest two violations of failure to supervise pharmacy
employees. Fine of $500, must attend law seminar
in addition to the required 15 hours of CE in 2013
and 2014, and all CE for 2013 and 2014 must be live.
(Agreed Order)
Walgreens No. 02361, #2-4841 – Case No. 1163: Did not
contest two violations including failure to maintain effective controls
against misfills and failure to supervise pharmacy employees. Fine: $6,000. (Agreed Order)
Ashley Howard, Technician #16063 – Case No. 1164:
Admitted guilt on four violations including theft of CDS
and possession of a CDS without a prescription resulting
in the loss of over 4,200 doses of CDS to the pharmacy
where she worked. Revoked. (Agreed Order)
Timothy Osborn, Technician #16150 – Case No. 1165:
Found guilty on five violations including theft of CDS
and possession of a CDS without a prescription. Revoked.
Dana Thompson, Technician #14550 – Case No. 1166:
Admitted guilt on four violations including theft of CDS
and possession of a CDS without a prescription. Revoked.
(Agreed Order)
Anthony Owens, DPh, #10513 – Case No. 1167: Admitted
guilt on five violations including failure to report disciplinary
action in another state, using an illegal CS, and
falsifying information on a pharmacist renewal. Indefinite
suspension. (Agreed Order)
Mercy Hospital Tishomingo, Inc, #61-6202 – Case No.
1168: Neither admitted nor denied guilt on three violations
including failure to be licensed, to obtain a license in a
timely manner after a change of ownership, and failure to
have a PIC. Fine: $9,000. (Agreed Order)
Wal-Mart Pharmacy No. 10-2804, #1-4460 – Case No.
1169: Neither admitted nor denied guilt on three violations
including failure to maintain effective controls against diversion
resulting in the loss of 9,788 doses of hydrocodone
products. Fine: $9,000. (Agreed Order)
Norman Regional Hospital Pharmacy, #7-523 – Case No.
1170: Admitted guilt on five violations including failure
to provide effective controls against theft and diversion
of CS and failure to maintain adequate records resulting
in the loss of over 4,200 doses of CDS. Fine: $6,000.
(Agreed Order)
13.29. May 15, 2013 Board Hearing
Doug Sisemore, DPh, #9159 – Case No. 1156: Admitted
guilt on 10 violations while acting as PIC of Reliable
Pharmacy including failure to establish and maintain effective controls
against the diversion of prescription drugs
and failing as pharmacy manager to be responsible for all
aspects of the pharmacy operation including the proper
record keeping system for drugs. Probation for five (5)
years and $10,000 fine. Must attend a law seminar in
addition to the required 15 hours of CE in 2013 and
2014 and all CE during the calendar years of 2013,
2014, and 2015 must be live CE. (Agreed Order)
Reliable Discount Pharmacy, Inc, #1-3893 – Case No.
1156: Admitted guilt on nine violations including failure
to properly maintain the required inventories and records
of CDS. Fine: $10,000. (Agreed Order)
Cindy Hudgins, Technician #13646 – Case No. 1171:
Admitted guilt on three violations including theft of CDS
and possession of a CDS without a prescription which
resulted in the loss of 1,097 doses of Schedule II CDS and
217,154 doses of Schedule III CDS to the pharmacy where
she worked. Revoked. (Agreed Order)
Sooner Pharmacy, Inc, of Tishomingo, #61-3493 – Case
No. 1172: Admitted guilt on 445 violations including
failure to provide effective controls and procedures to
guard against theft and diversion of CDS resulting in the
loss of 1,097 doses of Schedule II CDS and 217,154 doses Page 5 – July 2013
of Schedule III CDS. Probation for five (5) years and
$40,000 fine. (Agreed Order)
Michael Roy LaFevers, DPh, #9728 – Case No. 1173:
Admitted guilt on 447 violations while acting as PIC of
Sooner Pharmacy including failure as pharmacy manager
to establish and maintain effective controls and procedures
to guard against theft and diversion of CDS resulting in
the loss of 1,097 doses of Schedule II CDS and 217,154
doses of Schedule III CDS. Probation for five (5) years
and $15,000 fine. Must attend a law seminar in addition
to the required 15 hours of CE in 2013 and 2014 and
all CE must be live while on probation. (Agreed Order)
CVS/Pharmacy No. 08312, #26-5406 – Case No. 1174:
Admitted guilt on two violations including failure to keep
adequate records regarding 1,887 doses of controlled drug
substances. Fine: $3,000. (Agreed Order)
Brandon Maples, DPh, #13275 – Case No. 1175: Admitted
guilt on nine violations including administering drugs that
were not dispensed on orders from a prescribing practitioner. Indefinite suspension. (Agreed Order)
Red Cross Drug, #47-4751 – Case No. 1176: Admitted
guilt on 16 violations including failure to assign correct
beyond-use dates for sterile compounded drugs. Probation
for five (5) years and $20,000 fine. Parenteral permit is
suspended indefinitely. (Agreed Order)
Larry Kirkpatrick, DPh, #7942 – Case No. 1177: Admitted guilt on eight violations
while acting as PIC of Red Cross Drug including failure to assure compliance with
sterile compounding rules. Probation for five (5) years
and $1,000 fine. Must attend a law seminar in addition
to the required 15 hours of CE in 2013 and 2014 and
all CE must be live while on probation. (Agreed Order)
Vivien L. Grose, DPh, #11361 – Case No. 1178: Admitted
guilt on 34 violations while employed by Red Cross Drug
including failure to assign correct beyond-use dates for
sterile compounded drugs, and failure to assure compliance
with sterile compounding rules. Probation for five
(5) years and $2,000 fine. Must attend a law seminar
in addition to the required 15 hours of CE in 2013
and 2014 and all CE must be live while on probation.
(Agreed Order)
Ashley Weathers, Technician #2075 – Case No. 1179:
Admitted guilt on five violations including theft of personal
prescriptions and failure to notify the Board of address
change. Revoked. (Agreed Order)
Allen Community Pharmacy, #23-5285 – Case No. 1180:
Admitted guilt on nine violations including filling or refilling prescriptions for dangerous drugs without authorization
of a practitioner and failure to establish and maintain effective controls against the diversion of drugs. Probation
for five (5) years and $20,000 fine. (Agreed Order)
David Campbell, DPh, #12885 – Case No. 1181: Admitted guilt
on five violations
while acting as PIC of Allen
Community Pharmacy including failure to ensure that prescription
drugs are issued “by an authorized practitioner”
and failure to establish and maintain effective controls
against diversion of drugs. Probation for five (5) years
and $10,000 fine. Must attend a law seminar in addition
to the required 15 hours of CE in 2013 and 2014 and
all CE must be live while on probation. (Agreed Order)
Clay Haisten, DPh, #11522 – Case No. 1182: Admitted
guilt on 138 violations while acting as PIC of The Pharmacy of Pocola
including knowingly billing or charging
“for a brand when a generic or compounded product is
dispensed,” submitting fraudulent billing to a third-party
payer of prescription drugs, and compounding drug products
that are commercially available. Fined $15,000 and
remains on probation until October 3, 2017. Must attend a law
seminar in addition to the required 15 hours
of CE in 2013 and 2014 and all CE must be live while
on probation. (Agreed Order)
The Pharmacy of Pocola, #19-4449 – Case No. 1183:
Admitted guilt on 137 violations including submitting
fraudulent billing, and compounding drug products that
are commercially available. Probation for five (5) years
and $15,000 fine. (Agreed Order)
quoted from Oklahoma Board of Pharmacy July 2013 Newsletter
Sunday, May 5, 2013
Reminder Regarding Treatment of Tramadol Prescriptions in Oklahoma
Effective November 1, 2012, tramadol and all tramadol-containing products {are} classified as Schedule IV in the State of Oklahoma. Pharmacies are required to TAKE AN INVENTORY OF THEIR TRAMADOL PRODUCTS ON NOVEMBER 1ST AND KEEP IT WITH THEIR ANNUAL CDS INVENTORY (inventories do NOT have to be sent to the Board). Make sure that you start submitting all tramadol prescription information to the Prescription Monitoring Program (PMP) as required per OBNDD rules beginning November 1st as well.
Beginning November 1st:
- All tramadol-containing prescriptions older than six (6) months will be expired.
- All tramadol-containing prescriptions less than six (6) months old but with more than 5 refills already dispensed will be expired.
- All tramadol-containing prescriptions less than six (6) months old but with up to 5 refills remaining should be valid for the remainder of the six (6) months period and up to the remaining but not to exceed the 5 refills on a controlled prescription.
The pharmacist may have to rewrite the prescriptions for filing purposes. They need to be sure to reference them back properly to the original prescription number.
Quoted from here
Tuesday, March 5, 2013
Opinion March 5, 2013 Senate in Oklahoma approved Safe Compounding Act The Norman Transcript
NORMAN — By a vote of 42-0, the full Senate has approved my proposal to ensure that out-of-state compounding pharmacies doing business in Oklahoma are held to high standards of safety.
The Safe Compounding Act will require out-of-state compounding pharmacies that deliver, dispense or distribute prescription drugs in Oklahoma to submit an affidavit and pharmacy site inspection form to receive a license.
I was compelled to author this bill after learning about a tragic story in Massachusetts where a compounding pharmacy was linked to hundreds of cases of fungal meningitis and 23 deaths. Just four of 37 similar specialty pharmacies were able to pass surprise health inspections shortly after the story broke.
Under this bill, the Oklahoma Board of Pharmacy will be able to oversee pharmacies in other states that may not operate by the same stringent standards that ours do.
Source found here
Friday, February 22, 2013
UPDATE and REPOST From Jan. 26, 2013 : New Legislation Proposed In Oklahoma: But What's The Point Without More Inspectors and Actual Enforcement?
See this post for update: Bill has passed Senate and now goes to House for a vote.
While Standridge's bill is a start even if passed it will serve no purpose if there are not more and better inspections and enforcement of the laws and regulations. Anyone can sign an affidavit stating compliance with USP standards and FDA Good Manuafacturing Practices. What are the consequences for signing such an affidavit if it is false? And how does it work when the inspection in another state is based on different standards and laws than those in the state of Oklahoma? No problem if the other states' standards are higher, or is there? There is definitely a problem if the other state has lower inspection standards? Can you never do business in Oklahoma again if you submit a false affidavit? The bill provides no fine or consequences for failure to comply with the provisions. And is $100.00 really enough of an additional fee to charge out of state pharmacies who do business here? The bill provides for no additional funding at the Oklahoma State Board of Pharmacy. This also is another example of how complex and complicated the patchwork legislation can be for pharmacies to comply with in all states. This proposed legislation maybe a start in Oklahoma but is by no means a solution to the problems in the compounding world.
As note that Oklahoma State Senator Bingman has written Senate Bill 250, addressing workers compensation program reimbursement whereby compounded medications would be paid by the state's worker's compensation court at the rate of ingredient costs plus a $5.00 dispensing fee. Senate Bill 250 is a companion bill to pre-filed legislation in the Oklahoma House -- HB 1546.
State Senator and compounding pharmacist Rob Standridge pre-filed SB 522 bill in the Oklahoma Senate. SB 522 as written provides:
STATE OF OKLAHOMA
1st Session of the 54th Legislature (2013)
SENATE BILL 522 By: Standridge
AS INTRODUCED
An Act relating to nonresident pharmacies; requiring
nonresident pharmacies to submit certain information
in applications for license issuance or renewal;
providing for certain fees; providing for
codification; and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 355.3 of Title 59, unless there
is created a duplication in numbering, reads as follows:
As used in this act:
1. "Nonresident pharmacy" means any pharmacy located outside of
this state which delivers, dispenses, or distributes by any method
prescription drugs or devices to a user physically located in this
state, in addition to the initial application or renewal form and
other documents required for a pharmacy located in Oklahoma; and
2. "Pharmacist-in-charge" means a professionally competent,
legally qualified pharmacist responsible for compliance with all Req. No. 367
Page 2
laws and regulations governing the operation of the respective
pharmacy.
SECTION 2. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 355.4 of Title 59, unless there
is created a duplication in numbering, reads as follows:
A nonresident pharmacy, in addition to the initial application
or renewal form and other documents required for a pharmacy located
in Oklahoma, shall:
1. Submit an affidavit signed by the pharmacist-in-charge that
the pharmacy shall comply with non-sterile and sterile compounding
standards of the newest edition of the United States Pharmacopeial
and United States Food and Drug Administration Good Manufacturing
Practices;
2. a. Submit a pharmacy site inspection form completed and
signed within the previous eighteen (18) months by a
person authorized by the pharmacy's resident state
agency or board which is responsible for issuing
pharmacy licenses,
b. Submit a pharmacy site inspection form completed and
signed within the previous eighteen (18) months by a
staff person employed by the Oklahoma State Board of
Pharmacy and pay all costs incurred by the Board for
completion of the inspection, orReq. No. 367
Page 3
c. Submit an inspection report or certificate of
approval, from an organization approved by the
Oklahoma State Board of Pharmacy, which shall include
the standards and procedures to which the pharmacy
demonstrated compliance; and
3. Pay an additional fee of One Hundred Dollars ($100.00) over
and above the licensing and inspection fees charged to in-state
pharmacies to cover the additional costs associated with
administrative review and consideration of documents listed in
subparagraphs a, b and c of paragraph 2 of this section.
SECTION 3. This act shall become effective November 1, 2013.
54-1-367 JAM 1/25/2013 11:43:36 AM
The pre-filed bill would require non-resident pharmacies to complete an affidavit stating their compliance with USP standards and FDA Good Manufacturing Practices. Additionally, non-resident pharmacies would need to submit current inspection reports from their home state Board of Pharmacy and pay an additional fee for renewal.
While Standridge's bill is a start even if passed it will serve no purpose if there are not more and better inspections and enforcement of the laws and regulations. Anyone can sign an affidavit stating compliance with USP standards and FDA Good Manuafacturing Practices. What are the consequences for signing such an affidavit if it is false? And how does it work when the inspection in another state is based on different standards and laws than those in the state of Oklahoma? No problem if the other states' standards are higher, or is there? There is definitely a problem if the other state has lower inspection standards? Can you never do business in Oklahoma again if you submit a false affidavit? The bill provides no fine or consequences for failure to comply with the provisions. And is $100.00 really enough of an additional fee to charge out of state pharmacies who do business here? The bill provides for no additional funding at the Oklahoma State Board of Pharmacy. This also is another example of how complex and complicated the patchwork legislation can be for pharmacies to comply with in all states. This proposed legislation maybe a start in Oklahoma but is by no means a solution to the problems in the compounding world.
As note that Oklahoma State Senator Bingman has written Senate Bill 250, addressing workers compensation program reimbursement whereby compounded medications would be paid by the state's worker's compensation court at the rate of ingredient costs plus a $5.00 dispensing fee. Senate Bill 250 is a companion bill to pre-filed legislation in the Oklahoma House -- HB 1546.
Friday, February 8, 2013
Oklahoma Pharmacy Laws All in One Place
Proposed Rules Can be found at same website
Oklahoma Board of Pharmacy January 16, 2013 Meeting Focused On Compounding
AGENDA
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 1 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
8:00 a.m. Call meeting to order and record Board members present and absent in compliance with Open Meeting Act and Authority.
Approve minutes.
Approve expense claims.
Approve accrued expenses of the Executive Director.
Approve Oct-Dec 2012 leave reports of Executive Director.
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
1)
Canceled Pharmacist list.
2)
Canceled Pharmacy list.
3)
Canceled Facility list.
4)
Canceled Preceptor list.
5)
Canceled Technician list.
6)
Set future Board meetings.
7)
Request from Pharmacy Specialists Compounding Pharmacy.
8)
Executive Director’s report.
Review, discussion and possible Board action regarding yearly evaluation and possible salary adjustment of the Executive Director.
Proposed Executive Session pursuant to 25 O.S. Supp 2009, § 307 (B) (1)
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
9:00 a.m. Evidentiary Hearing on Complaints
OSBP vs. Shaun Davis, Technician #16785 – Case No. 1140
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Celeste Hendrickson, Technician #11527 – Case No. 1141
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Jamaal Walker, Technician #9521 – Case No. 1145
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Nicole Mullicane, Technician #13513 – Case No. 1147
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. James Myers, Technician #12483 – Case No. 1146
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Laura Matlock, Technician #6402 – Case No. 1148
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Brandi McKnight, Technician #16429 – Case No. 1149 - continued
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Cherri Stark, Technician #14754 – Case No. 1150
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Michael Payne, Technician #16629 – Case No. 1151
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
AGENDA
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 2 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
Review, Discussion and Possible Action Regarding granting application for
technician permit to Afsana Begum.
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
Board visits with Reciprocity & NAPLEX applicants.
Reciprocity: NAPLEX:
Nicholas Chung............WA Deborah Cookson
Stewart Chung .............IL
Brandon Maydew .........WI
Michael McDonald .......TX
Pamela Njikam.............TX
Bhavesh Patel..............IL
Heather Weaver...........VA
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
10:00 a.m. Evidentiary Hearing on Complaints
OSBP vs. Shane B. Leu, D.Ph. #12317 – Case No. 1153
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Danielle Adams, D.Ph. #14486 – Case No. 1144
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
12:00 p.m. LUNCH
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
1:00 p.m. Evidentiary Hearing on Complaints
OSBP vs. Oklahoma Respiratory Care, #7-D-1323 and Oklahoma Respiratory
Care, #7-D-420 – Case No. 1157
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Catherine Mattea Tate, D.Ph. #14362 – Case No. 1126 – Requesting
Probation
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
ADJOURN BOARD MEETING TO HOLD RULE HEARING AT 2:00 PM
AGENDA
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 3 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
2:00 p.m. Call meeting to order and record Board members present and absent in Compliance with Open Meeting Act and Authority.
Rule Hearing for Public comment:
2013 Draft Rule Revisions – Title 535: Chapters 1, 13 & 15
TITLE 535. OKLAHOMA STATE BOARD OF PHARMACY
CHAPTER 1. ADMINISTRATIVE OPERATIONS
Subchapter 14. Scheduled or Controlled Dangerous Substances Classifications or Exclusions
535:1-14-4. Exclusion of Rx Only products not federally scheduled from Oklahoma controlled substance scheduling
SUMMARY: Remove OAC 535:1-14-4 (b) - no exempt butalbital products.
CHAPTER 13. EMERGENCY / DISASTER PRESCRIPTION DRUG RULES PHARMACY RESPONSE
535:13-1-1. Purpose [AMENDED]
535:13-1-3. Declaration of Emergency [AMENDED]
535:13-1-4. Pharmacy Emergency / Disaster Response [AMENDED]
SUMMARY: 535:13-1-1, 535:13-1-3 and 535:13-1-4 add medical gas suppliers and medical gas distributors to emergency prescription drug rules.
CHAPTER 15. PHARMACIES
SUBCHAPTER 3. PHARMACIES
535:15-3-12. Transfer of prescription refill information [AMENDED]
SUBCHAPTER 10. GOOD COMPOUNDING PRACTICES
535:15-10-3. Pharmacist responsibilities [AMENDED]
535:15-10-64. Compounding for institution and/or practitioner administration [AMENDED]
SUBCHAPTER 16. PHARMACY EMERGENCY MEDICATION KITS FOR USE IN A FACILITY
535:15-16-4. Policies and procedures for use of emergency medication kit drugs [AMENDED]
SUMMARY: 535:15-3-12 revises prescription transfer rules. 535:15-10-3 (c) (10) (D) removes “sterile” from the non-sterile rules. 535:15-10-64 (c) removes “Compounding” from the Drug Supplier Permit. 535:15-16-4 (d) adds “a practitioners order” to emergency medication kit rules. Revisions improve clarity.
Board may vote to approve, disapprove or amend 2013 Draft Rule Revisions.
Adjournment
Wednesday, February 6, 2013
More Proposed Legislation in Oklahoma relating to Pharmacies
Ok Bill #HB2100 permits Board of Pharmacy to suspend PBM's license or impose fines for noncompliance with regs, or unfair business practices and also mandates that PBMs may not require accreditation/licensing of providers other than by the Board or State/federal government. Click here to review bill
Tuesday, January 29, 2013
Oklahoma State Board of Pharmacy Inspections Stats
From information provided by Cindy Hamilton, D. Ph. Chief Compliance Officer for the Oklahoma State Board of Pharmacy, the Oklahoma Board of Pharmacy conducted 1173 inspections in 2011 and 1155 inspections in 2012. Oklahoma has 1142 pharmacies and 400 facilities located in the State of Oklahoma. These inspections include pharmacies and facilities (medical gas suppliers, wholesalers, manufacturers, etc.) The Oklahoma Pharmacy Board attempts to inspect each registrant once a year unannounced. However, for the past two years the Oklahoma Pharmacy Board has been short a compliance officer. The board does not keep individual statistics on the number of compounding pharmacies inspected.
Saturday, January 26, 2013
New Legislation Proposed In Oklahoma: But What's The Point Without More Inspectors and Actual Enforcement?
State Senator and compounding pharmacist Rob Standridge pre-filed SB 522 bill in the Oklahoma Senate. SB 522 as written provides:
STATE OF OKLAHOMA
1st Session of the 54th Legislature (2013)
SENATE BILL 522 By: Standridge
AS INTRODUCED
An Act relating to nonresident pharmacies; requiring nonresident pharmacies to submit certain information
in applications for license issuance or renewal;
providing for certain fees; providing for
codification; and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 355.3 of Title 59, unless there
is created a duplication in numbering, reads as follows:
As used in this act:
1. "Nonresident pharmacy" means any pharmacy located outside of
this state which delivers, dispenses, or distributes by any method
prescription drugs or devices to a user physically located in this
state, in addition to the initial application or renewal form and
other documents required for a pharmacy located in Oklahoma; and
2. "Pharmacist-in-charge" means a professionally competent,
legally qualified pharmacist responsible for compliance with all Req. No. 367
Page 2
laws and regulations governing the operation of the respective
pharmacy.
SECTION 2. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 355.4 of Title 59, unless there
is created a duplication in numbering, reads as follows:
A nonresident pharmacy, in addition to the initial application
or renewal form and other documents required for a pharmacy located
in Oklahoma, shall:
1. Submit an affidavit signed by the pharmacist-in-charge that
the pharmacy shall comply with non-sterile and sterile compounding
standards of the newest edition of the United States Pharmacopeial
and United States Food and Drug Administration Good Manufacturing
Practices;
2. a. Submit a pharmacy site inspection form completed and
signed within the previous eighteen (18) months by a
person authorized by the pharmacy's resident state
agency or board which is responsible for issuing
pharmacy licenses,
b. Submit a pharmacy site inspection form completed and
signed within the previous eighteen (18) months by a
staff person employed by the Oklahoma State Board of
Pharmacy and pay all costs incurred by the Board for
completion of the inspection, orReq. No. 367
Page 3
c. Submit an inspection report or certificate of
approval, from an organization approved by the
Oklahoma State Board of Pharmacy, which shall include
the standards and procedures to which the pharmacy
demonstrated compliance; and
3. Pay an additional fee of One Hundred Dollars ($100.00) over
and above the licensing and inspection fees charged to in-state
pharmacies to cover the additional costs associated with
administrative review and consideration of documents listed in
subparagraphs a, b and c of paragraph 2 of this section.
SECTION 3. This act shall become effective November 1, 2013.
54-1-367 JAM 1/25/2013 11:43:36 AM
The pre-filed bill would require non-resident pharmacies to complete an affidavit stating their compliance with USP standards and FDA Good Manufacturing Practices. Additionally, non-resident pharmacies would need to submit current inspection reports from their home state Board of Pharmacy and pay an additional fee for renewal.
While Standridge's bill is a start even if passed it will serve no purpose if there are not more and better inspections and enforcement of the laws and regulations. Anyone can sign an affidavit stating compliance with USP standards and FDA Good Manuafacturing Practices. What are the consequences for signing such an affidavit if it is false? And how does it work when the inspection in another state is based on different standards and laws than those in the state of Oklahoma? No problem if the other states' standards are higher, or is there? There is definitely a problem if the other state has lower inspection standards? Can you never do business in Oklahoma again if you submit a false affidavit? The bill provides no fine or consequences for failure to comply with the provisions. And is $100.00 really enough of an additional fee to charge out of state pharmacies who do business here? The bill provides for no additional funding at the Oklahoma State Board of Pharmacy. This also is another example of how complex and complicated the patchwork legislation can be for pharmacies to comply with in all states. This proposed legislation maybe a start in Oklahoma but is by no means a solution to the problems in the compounding world.
As note that Oklahoma State Senator Bingman has written Senate Bill 250, addressing workers compensation program reimbursement whereby compounded medications would be paid by the state's worker's compensation court at the rate of ingredient costs plus a $5.00 dispensing fee. Senate Bill 250 is a companion bill to pre-filed legislation in the Oklahoma House -- HB 1546.
Wednesday, January 16, 2013
Oklahoma State Board of Pharmacy Meeting Today, January 16, 2013
AGENDA
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 1 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
8:00 a.m. Call meeting to order and record Board members present and absent in
compliance with Open Meeting Act and Authority.
Approve minutes.
Approve expense claims.
Approve accrued expenses of the Executive Director.
Approve Oct-Dec 2012 leave reports of Executive Director.
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
1) Canceled Pharmacist list.
2) Canceled Pharmacy list.
3) Canceled Facility list.
4) Canceled Preceptor list.
5) Canceled Technician list.
6) Set future Board meetings.
7) Request from Pharmacy Specialists Compounding Pharmacy.
8) Executive Director’s report.
Review, discussion and possible Board action regarding yearly evaluation
and possible salary adjustment of the Executive Director.
Proposed Executive Session pursuant to 25 O.S. Supp 2009, § 307 (B) (1)
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
9:00 a.m. Evidentiary Hearing on Complaints
OSBP vs. Shaun Davis, Technician #16785 – Case No. 1140
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Celeste Hendrickson, Technician #11527 – Case No. 1141
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Jamaal Walker, Technician #9521 – Case No. 1145
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Nicole Mullicane, Technician #13513 – Case No. 1147
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. James Myers, Technician #12483 – Case No. 1146
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Laura Matlock, Technician #6402 – Case No. 1148
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Brandi McKnight, Technician #16429 – Case No. 1149
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Cherri Stark, Technician #14754 – Case No. 1150
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Michael Payne, Technician #16629 – Case No. 1151
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action. AGENDA
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 2 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
Review, Discussion and Possible Action Regarding granting application for
technician permit to Afsana Begum.
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
Board visits with Reciprocity & NAPLEX applicants.
Reciprocity: NAPLEX:
Nicholas Chung............WA Deborah Cookson
Stewart Chung .............IL
Brandon Maydew .........WI
Michael McDonald .......TX
Pamela Njikam.............TX
Bhavesh Patel..............IL
Heather Weaver...........VA
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
10:00 a.m. Evidentiary Hearing on Complaints
OSBP vs. Shane B. Leu, D.Ph. #12317 – Case No. 1153
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Danielle Adams, D.Ph. #14486 – Case No. 1144
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
12:00 p.m. LUNCH
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
1:00 p.m. Evidentiary Hearing on Complaints
OSBP vs. Oklahoma Respiratory Care, #7-D-1323 and Oklahoma Respiratory
Care, #7-D-420 – Case No. 1157
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Catherine Mattea Tate, D.Ph. #14362 – Case No. 1126 – Requesting
Probation
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
ADJOURN BOARD MEETING TO HOLD RULE HEARING AT 2:00 PM
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 1 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
8:00 a.m. Call meeting to order and record Board members present and absent in
compliance with Open Meeting Act and Authority.
Approve minutes.
Approve expense claims.
Approve accrued expenses of the Executive Director.
Approve Oct-Dec 2012 leave reports of Executive Director.
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
1) Canceled Pharmacist list.
2) Canceled Pharmacy list.
3) Canceled Facility list.
4) Canceled Preceptor list.
5) Canceled Technician list.
6) Set future Board meetings.
7) Request from Pharmacy Specialists Compounding Pharmacy.
8) Executive Director’s report.
Review, discussion and possible Board action regarding yearly evaluation
and possible salary adjustment of the Executive Director.
Proposed Executive Session pursuant to 25 O.S. Supp 2009, § 307 (B) (1)
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
9:00 a.m. Evidentiary Hearing on Complaints
OSBP vs. Shaun Davis, Technician #16785 – Case No. 1140
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Celeste Hendrickson, Technician #11527 – Case No. 1141
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Jamaal Walker, Technician #9521 – Case No. 1145
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Nicole Mullicane, Technician #13513 – Case No. 1147
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. James Myers, Technician #12483 – Case No. 1146
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Laura Matlock, Technician #6402 – Case No. 1148
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Brandi McKnight, Technician #16429 – Case No. 1149
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Cherri Stark, Technician #14754 – Case No. 1150
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Michael Payne, Technician #16629 – Case No. 1151
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action. AGENDA
JANUARY 16, 2013
“Regular Meeting”
OKLAHOMA STATE BOARD OF PHARMACY
4545 N Lincoln Boulevard, Suite 112, Oklahoma City, Oklahoma 73105-3413
Page 2 of 3
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
Review, Discussion and Possible Action Regarding granting application for
technician permit to Afsana Begum.
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
Board visits with Reciprocity & NAPLEX applicants.
Reciprocity: NAPLEX:
Nicholas Chung............WA Deborah Cookson
Stewart Chung .............IL
Brandon Maydew .........WI
Michael McDonald .......TX
Pamela Njikam.............TX
Bhavesh Patel..............IL
Heather Weaver...........VA
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
10:00 a.m. Evidentiary Hearing on Complaints
OSBP vs. Shane B. Leu, D.Ph. #12317 – Case No. 1153
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Danielle Adams, D.Ph. #14486 – Case No. 1144
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
12:00 p.m. LUNCH
FOR REVIEW, DISCUSSION AND POSSIBLE BOARD ACTION:
1:00 p.m. Evidentiary Hearing on Complaints
OSBP vs. Oklahoma Respiratory Care, #7-D-1323 and Oklahoma Respiratory
Care, #7-D-420 – Case No. 1157
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
OSBP vs. Catherine Mattea Tate, D.Ph. #14362 – Case No. 1126 – Requesting
Probation
Proposed Executive Session pursuant to 25 O.S. Supp 2008, § 307 (B) (8); possible Board action.
ADJOURN BOARD MEETING TO HOLD RULE HEARING AT 2:00 PM
Sunday, December 23, 2012
Fake Drugs in Oklahoma: Synthetic Drug Problem
December 21, 2012
Fake drugs; right here
Staff Writer Cydney Baron
PRYOR — Fake drugs are a real problem in Mayes County
Anyone can buy synthetic versions of various drugs at gas stations, convenience stores, novelty stores, and head shops. Most popular are synthetic marijuana, or “fake weed,” and party pills. The Oklahoma Bureau of Narcotics says manufacturers have flooded the market over the past few years with synthetic products that mimic actual street drugs.
Synthetic marijuana is being packaged and sold as herbal and organic. The suggested use, according to the label, is incense or potpourri. Smoking this “fake weed,” produces a high quite similar to the real thing.
It all started with K2, the original synthetic marijuana. K2, also called Spice, produces a high but comes with dangerous, often deadly side effects. The chemical compounds found in K2 can cause hallucinations, increased heart rate, seizures, anxiety, paranoia and death. K2, and all the brands following it, are sold by the gram or the ounce and marketed to teens. As laws and legislation are passed outlawing different strands of synthetic marijuana, developers reformulate, repackage and get around the laws.
Party pills are another deadly trend. These pills are sold as copies of substances such as Adarol, Xanax, cocaine and Ecstasy. Party pills are as readily available as synthetic marijuana, and can easily be purchased online. Due to unreliable manufacturers, the side effects of these pills are dangerously unpredictable.
The Oklahoma Bureau of Narcotics reports that many teenagers think these synthetic drugs are safe alternatives to street drugs, because they are sold legally in local convenience stores. Oklahoma Senate Bill 919 banned two classes of synthetic drugs, synthetic cannabinoids and synthetic cathinone. It outlaws approximately 250 different synthetic chemicals found in these fake drugs. Possession or sales of these products can result in felony charges and a prison term of up to 10 years.
While these trends are seen on national news, locals say they are a problem right here in Mayes County.
“It has become a huge problem in Mayes County,” says Lt. Alan Davis.“We have had a lot of medical runs because of these synthetic drugs. People have serious reactions to it.”
The laws regarding these synthetic drugs are a little hazy. Davis explains why.
“It’s not possible to say which brands are legal and which are not. The chemical compounds in these drugs are what have been made illegal,” said Davis.“These substances come from overseas and there is no regulation on what compounds are used in which ‘brands’ of synthetic drugs.”
Essentially, there is no way of knowing what compound is in each drug as the manufacturers mix and match. Not only does this make the substances more dangerous, but it makes it harder to eradicate.
“Any of these synthetic drugs are illegal if you buy or sell them with the intent to use them for consumption,” said Davis.
Many people who use these synthetic drugs believe they will not get caught, as there is no field test that will determine if one of the illegal compounds is present. Davis said this is not the case.
“There is no field test we can do to test for these compounds, however, if someone is caught with synthetic marijuana, for instance, I will seize it and send it in to be tested,” said Davis.“If the substance tests positive for one of the illegal compounds, I will issue a warrant for their arrest.”
Local law enforcement says the problem has become so widespread, it is not just teenagers anymore. People assume that because something is more readily available that is both legal and safe.
“People don’t seem to understand this stuff is deadly,” said Davis.
Local officials say party pills are every bit as dangerous, but have not been as much of a problem as synthetic marijuana so far.
http://pryordailytimes.com/local/x1633432953/...
Fake drugs; right here
Staff Writer Cydney Baron
PRYOR — Fake drugs are a real problem in Mayes County
Anyone can buy synthetic versions of various drugs at gas stations, convenience stores, novelty stores, and head shops. Most popular are synthetic marijuana, or “fake weed,” and party pills. The Oklahoma Bureau of Narcotics says manufacturers have flooded the market over the past few years with synthetic products that mimic actual street drugs.
Synthetic marijuana is being packaged and sold as herbal and organic. The suggested use, according to the label, is incense or potpourri. Smoking this “fake weed,” produces a high quite similar to the real thing.
It all started with K2, the original synthetic marijuana. K2, also called Spice, produces a high but comes with dangerous, often deadly side effects. The chemical compounds found in K2 can cause hallucinations, increased heart rate, seizures, anxiety, paranoia and death. K2, and all the brands following it, are sold by the gram or the ounce and marketed to teens. As laws and legislation are passed outlawing different strands of synthetic marijuana, developers reformulate, repackage and get around the laws.
Party pills are another deadly trend. These pills are sold as copies of substances such as Adarol, Xanax, cocaine and Ecstasy. Party pills are as readily available as synthetic marijuana, and can easily be purchased online. Due to unreliable manufacturers, the side effects of these pills are dangerously unpredictable.
The Oklahoma Bureau of Narcotics reports that many teenagers think these synthetic drugs are safe alternatives to street drugs, because they are sold legally in local convenience stores. Oklahoma Senate Bill 919 banned two classes of synthetic drugs, synthetic cannabinoids and synthetic cathinone. It outlaws approximately 250 different synthetic chemicals found in these fake drugs. Possession or sales of these products can result in felony charges and a prison term of up to 10 years.
While these trends are seen on national news, locals say they are a problem right here in Mayes County.
“It has become a huge problem in Mayes County,” says Lt. Alan Davis.“We have had a lot of medical runs because of these synthetic drugs. People have serious reactions to it.”
The laws regarding these synthetic drugs are a little hazy. Davis explains why.
“It’s not possible to say which brands are legal and which are not. The chemical compounds in these drugs are what have been made illegal,” said Davis.“These substances come from overseas and there is no regulation on what compounds are used in which ‘brands’ of synthetic drugs.”
Essentially, there is no way of knowing what compound is in each drug as the manufacturers mix and match. Not only does this make the substances more dangerous, but it makes it harder to eradicate.
“Any of these synthetic drugs are illegal if you buy or sell them with the intent to use them for consumption,” said Davis.
Many people who use these synthetic drugs believe they will not get caught, as there is no field test that will determine if one of the illegal compounds is present. Davis said this is not the case.
“There is no field test we can do to test for these compounds, however, if someone is caught with synthetic marijuana, for instance, I will seize it and send it in to be tested,” said Davis.“If the substance tests positive for one of the illegal compounds, I will issue a warrant for their arrest.”
Local law enforcement says the problem has become so widespread, it is not just teenagers anymore. People assume that because something is more readily available that is both legal and safe.
“People don’t seem to understand this stuff is deadly,” said Davis.
Local officials say party pills are every bit as dangerous, but have not been as much of a problem as synthetic marijuana so far.
http://pryordailytimes.com/local/x1633432953/...
Subscribe to:
Posts (Atom)